<DOC>
	<DOCNO>NCT02307630</DOCNO>
	<brief_summary>The purpose study find antibody call Hu3F8 travel body tumor . Antibodies , like Hu3F8 , proteins help attack tumor fight infection . Antibodies make body laboratory . The target antibody call antigen ; antibody fit antigen like lock fit key .</brief_summary>
	<brief_title>PET Imaging Solid Tumors Using 124I-Humanized 3F8 : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>Patients diagnosis neuroblastoma must meet following criterion : Diagnosis confirm histological assessment MSKCC Department pathology presence BM metastases PLUS elevate urinary catecholamine Relapsed refractory stage 4 disease relapse refractory stage MYCNamplified 2B 3 disease . Patients tumor neuroblastoma must meet following criterion : Have one follow diagnosis ( tumor know express GD2 cell surface ) : Melanoma Osteogenic sarcoma Leiomyosarcoma Ewing sarcoma Liposarcoma Fibrosarcoma Malignant fibrous histiocytoma Spindle cell sarcoma Small cell lung cancer Medulloblastoma metastatic extracranial site Paraganglioma Have refractory relapse metastatic disease Patients solid tumor diagnose OTHER neuroblastoma list eligible meet follow criterion : Immunohistochemical demonstration GD2 expression cell surface ( Tumor assessment immunohistochemistry require group patient ) Have refractory relapsed disease metastatic disease . All patient must measurable evaluable disease Age 390 year Prior treatment antiGD2 monoclonal antibody permit human antihuman antibody titer ≤1300 assay develop Dr. NaiKong Cheung . Negative serum pregnancy test woman childbearing potential Women childbearing potential must willing practice effective method birth control study Signed informed consent indicate awareness investigational nature study . Existing major organ dysfunction &gt; grade 2 , exception myelosuppression ( neutrophil count &gt; = 500/μl platelet count &gt; = 25,000/μl acceptable ) hearing loss . Acute life threaten infection Requirement sedation PET/CT scan Pregnant woman woman breastfeed . Inability comply protocol requirement . Hypersensitivity potassium iodide Lugols product Prior development positive human antimouse antibody response ( HAMA ) human antihuman antibody response ( HAHA ) Positive human antihu3F8 antibody titer .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>124I-Humanized 3F8</keyword>
	<keyword>PET Imaging</keyword>
	<keyword>13-147</keyword>
</DOC>